These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3601536)
1. [Clinical characteristics of chronic hepatitis B in children and the principles of its staged treatment]. Gol'zand IV; Murav'eva NN; Goriacheva LG; Bulovskaia LN; Gorvat NA Pediatriia; 1987; (3):40-4. PubMed ID: 3601536 [No Abstract] [Full Text] [Related]
2. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases]. Iakhontova OI; Dudanova OP; Khavinson VKh Sov Med; 1990; (6):85-8. PubMed ID: 2396134 [No Abstract] [Full Text] [Related]
3. [Indications for using thymalin in the therapy of children with chronic viral hepatitis B]. Gol'zand IV; Goriacheva LG; Volkov VO; Khavinson VKh; Morozov VG Voen Med Zh; 1986 Mar; (3):27-8. PubMed ID: 3487166 [No Abstract] [Full Text] [Related]
4. [Immunomodulator therapy in chronic viral hepatitis]. Stanciu L Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):491-502. PubMed ID: 2484221 [No Abstract] [Full Text] [Related]
5. [Indicators of cellular immunity in various types of treatment of children with chronic hepatitis B]. Idrisova RS; Tsoĭ IG Pediatriia; 1984 Aug; (8):16-8. PubMed ID: 6333670 [No Abstract] [Full Text] [Related]
6. [Changes in the cellular reactions in children with chronic hepatitis B, and the use of immunoregulatory drugs]. Gol'zand IV; Goriacheva IG; Volkov VO; Romantsov MG; Khavinson VG Pediatriia; 1984 Aug; (8):12-5. PubMed ID: 6333669 [No Abstract] [Full Text] [Related]
7. [Effect of dimephosphon on the clinico-immunological indicators in children with chronic hepatitis]. Gorbunova IV; Shabunina EI; Maianskaia IV; Studentsova IA Pediatriia; 1991; (10):111-2. PubMed ID: 1787992 [No Abstract] [Full Text] [Related]
8. [Chronic active hepatitis B in children: effects of various methods of treatment]. Egorov VB; Gol'zand IV Pediatriia; 1991; (2):52-6. PubMed ID: 2057294 [No Abstract] [Full Text] [Related]
9. Levamisole therapy in chronic type hepatitis. Fattovich G; Alberti A; Realdi G Hepatology; 1988; 8(1):196-7. PubMed ID: 3338714 [No Abstract] [Full Text] [Related]
10. Levamisole and chronic delta hepatitis. Arrigoni A; Ponzetto A; Actis G; Bonino F Ann Intern Med; 1983 Jun; 98(6):1024. PubMed ID: 6859689 [No Abstract] [Full Text] [Related]
12. [Hepatological news (2). The twilight of immunosuppression in hepatitis B--the dawn of new methods?]. Juszczyk J Pol Tyg Lek; 1982 Nov; 37(43):1295-300. PubMed ID: 6761672 [No Abstract] [Full Text] [Related]
13. [Markers of chronic hepatitis B in children after completion of therapy with isoprinosine]. Kowalik-Mikołajewska B; Barszcz T; Ladyzyńska E; Wojnarowski M Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):263-4. PubMed ID: 7694263 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of chronic hepatitis and liver cirrhosis]. Grigor'ev PIa; Iakovenko EP Sov Med; 1985; (12):61-7. PubMed ID: 4095635 [No Abstract] [Full Text] [Related]
15. [Dynamics of immunological indices in patients with chronic viral hepatitis B and the effect of thymalin therapy]. Gol'zand IV; Murav'eva NN; Goriacheva LG Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):38-41. PubMed ID: 2945347 [TBL] [Abstract][Full Text] [Related]
16. [Current aspects of the therapy of chronic hepatitis (a review of the literature)]. Cherednichenko TV Vopr Okhr Materin Det; 1979 Nov; 24(11):43-8. PubMed ID: 388858 [No Abstract] [Full Text] [Related]
17. [Cellular immunity and its correction in patients with a preulcerous condition]. Uspenskiĭ VM; Valuevich VV; Novikova IA Vrach Delo; 1987 Sep; (9):40-2. PubMed ID: 3424771 [No Abstract] [Full Text] [Related]
18. [Use of reaferon and antioxidants in children with chronic hepatitis]. Frolov VM; Peresadin NA; Sidorova VS; Germanov VT; Pustovoĭ IuG Pediatriia; 1992; (4-6):60-2. PubMed ID: 1408577 [No Abstract] [Full Text] [Related]